45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
13,629
Insurances with rates
3
CPT / HCPCS codes
11,290
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 48729 | NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML IVES SUSP | $87,000 | $60,900 | — | — | 0 |
| 48105 | GLOFITAMAB-GXBM 1 MG/ML IV SOLN (>10 MG DOSE 10 ML MIXTURE COMPONENT) | $84,614 | $59,230 | — | — | 0 |
| 49698 | DATOPOTAMAB DERUXTECAN-DLNK 100 MG IV SOLR | $72,897 | $51,028 | — | — | 0 |
| 46241 | TISOTUMAB VEDOTIN-TFTV 40 MG IV SOLR | $67,499 | $47,249 | — | — | 0 |
| 47433 | NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20 ML IV SOLN | $56,694 | $39,686 | — | — | 0 |
| 43219 | BRENTUXIMAB VEDOTIN 50 MG IV SOLR | $50,650 | $35,455 | — | — | 0 |
| 41099 | PEMBROLIZUMAB 100 MG/4 ML (25 MG/ML) IV SOLN | $48,364 | $33,855 | — | — | 0 |
| 34032 | YTTRIUM-90 (Y-90 THERASPHERE) GLASS MICROSPHERES | $44,379 | $31,065 | — | — | 0 |
| 49107 | LONCASTUXIMAB TESIRINE-LPYL 10 MG IV SOLR | $43,684 | $30,579 | — | — | 0 |
| 48723 | TARLATAMAB-DLLE 10 MG IV SOLR | $41,400 | $28,980 | — | — | 0 |
| 49118 | TARLATAMAB-DLLE 10 MG IV SOLR | $41,381 | $28,967 | — | — | 0 |
| 44919 | SIROLIMUS-PROTEIN BOUND 100 MG IV SUSR (WET SUSR VIAL) | $38,872 | $27,210 | — | — | 0 |
| 31590 | LURBINECTEDIN 4 MG IV SOLR | $36,615 | $25,631 | — | — | 0 |
| 25339 | EMICIZUMAB-KXWH 105 MG/0.7 ML SUBQ SOLN | $35,039 | $24,527 | — | — | 0 |
| 46784 | DOSTARLIMAB-GXLY 50 MG/ML IV SOLN | $30,675 | $21,473 | — | — | 0 |
| 33152 | TESTOSTERONE 75 MG IMPL PLLT | $29,210 | $20,447 | — | — | 0 |
| 46427 | TREMELIMUMAB-ACTL 20 MG/ML IV SOLN | $26,910 | $18,837 | — | — | 0 |
| 22762 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) IV SOLN | $26,490 | $18,543 | — | — | 0 |
| 8690 | LANREOTIDE 120 MG/0.5 ML SUBQ SYRG | $26,392 | $18,474 | — | — | 0 |
| 49225 | TORIPALIMAB-TPZI 240 MG/6 ML (40 MG/ML) IV SOLN | $25,650 | $17,955 | — | — | 0 |
| 38133 | CEMIPLIMAB-RWLC 50 MG/ML IV SOLN | $25,491 | $17,844 | — | — | 0 |
| 41109 | CABAZITAXEL 10 MG/ML (FINAL) IV SOLN | $24,543 | $17,180 | — | — | 0 |
| 45000385 | HC OPEN TX TRIMALLEOLAR ANKLE FX INCL INT FIXATION MEDIAL/ LATERAL MALLEOLUS W/O FIXATION POST LIP | $23,881 | $16,717 | — | — | 0 |
| 44221 | PERTUZUMAB-TRASTUZUMAB-HY-ZZXF 600 MG-600 MG- 20000 UNIT/10ML SUBQ SOLN | $23,380 | $16,366 | — | — | 0 |
| 31881 | BEVACIZUMAB-AWWB 25 MG/ML IV SOLN | $23,109 | $16,176 | — | — | 0 |
| 49775 | TISLELIZUMAB-JSGR 10 MG/ML IV SOLN | $23,077 | $16,154 | — | — | 0 |
| 31562 | DARATUMUMAB-HYALURONIDASE-FIHJ 1,800 MG-30,000 UNIT/15 ML SUBQ SOLN | $20,904 | $14,633 | — | — | 0 |
| 43293 | PANITUMUMAB 400 MG/20 ML (20 MG/ML) IV SOLN | $20,001 | $14,001 | — | — | 0 |
| 30653 | PERTUZUMAB 420 MG/14 ML (30 MG/ML) IV SOLN | $18,749 | $13,124 | — | — | 0 |
| 11021 | RABIES IMMUNE GLOBULIN (PF) 300 UNIT/ML IM SOLN | $17,892 | $12,524 | — | — | 0 |
| 31766 | ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) IV SOLN | $17,763 | $12,434 | — | — | 0 |
| 11439 | TRASTUZUMAB 150 MG IV SOLR | $17,205 | $12,044 | — | — | 0 |
| 36100124 | HC INSERT TUNNEL CV DEVICE >5 YRS | $15,988 | $11,192 | — | — | 0 |
| 46561 | PEMIVIBART 125 MG/ML IV SOLN | $15,939 | $11,157 | — | — | 0 |
| 8655 | IMMUNE GLOBULIN(HUM),CAPR(IGG) 5 GRAM/50 ML (10 %) INJ SOLN | $15,559 | $10,891 | — | — | 0 |
| 34738 | AVELUMAB 20 MG/ML IV SOLN | $14,907 | $10,435 | — | — | 0 |
| 35333 | BENRALIZUMAB 30 MG/ML SUBQ ATIN | $14,769 | $10,338 | — | — | 0 |
| 25050 | RITUXIMAB-HYALURONIDASE,HUMAN 1400 MG/11.7 ML (120 MG/ML) SUBQ SOLN | $13,985 | $9,790 | — | — | 0 |
| 39886 | SACITUZUMAB GOVITECAN-HZIY 180 MG IV SOLR | $13,858 | $9,701 | — | — | 0 |
| 35979 | POLATUZUMAB VEDOTIN-PIIQ 20 MG/ML IV WET SOLR VIAL (RECON 140 MG VIAL) | $13,840 | $9,688 | — | — | 0 |
| 75000127 | HC ENDOSCOPIC CANNULATION OF PAPILLA WITH DIRECT VISUALIZATION OF PANCREATIC/COMMON BILE DUCT(S) | $13,660 | $9,562 | — | — | 0 |
| 41094 | CETUXIMAB 100 MG/50 ML IV SOLN | $13,449 | $9,414 | — | — | 0 |
| 45000396 | HC CLOSED TREATMENT MANDIBULAR/MAXILLARY ALVEOLAR RIDGE FX | $13,112 | $9,178 | — | — | 0 |
| 45000407 | HC REMOVAL FOREIGN BODY IN SCROTUM | $12,974 | $9,082 | — | — | 0 |
| 36481 | TRASTUZUMAB-HYALURONIDASE-OYSK 600 MG-10,000 UNIT/5 ML SUBQ SOLN | $12,904 | $9,033 | — | — | 0 |
| 16206 | OCTREOTIDE,MICROSPHERES 30 MG IM SERR | $12,720 | $8,904 | — | — | 0 |
| 66385 | COAGULATION FACTOR VIIA RECOMB (PHS ERX MERGE) | $12,374 | $8,662 | — | — | 0 |
| 45000395 | HC REMOVAL OF FOREIGN BODY DEEP THIGH REGION OR KNEE AREA | $12,284 | $8,599 | — | — | 0 |
| 45000397 | HC REMOVAL FOREIGN BODY MUSCLE/TENDON SHEATH DEEP OR COMPLICATED | $12,284 | $8,599 | — | — | 0 |
| 36101058 | HC REVISION INCL REPLACEMENT SPINAL NEUROSTIMULATOR ELECTRODE PLATE/PADDLE(S) LAMINOTOMY/LAMINECTOMY | $12,273 | $8,591 | — | — | 0 |
Showing top 50 of 13,629 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.